Trademark: 97002052
Status Date
Thursday, January 25, 2024
Filing Date
Monday, August 30, 2021
Published for Opposition
Tuesday, January 11, 2022
5 Medicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans, namely, for the treatment of neuroinflammatory and neurodegenerative diseases and disorders, and for neuroprotection
Jan 27, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 25, 2024
Sou Extension 4 Granted
Jan 25, 2024
Sou Extension 4 Filed
Jan 25, 2024
Sou Teas Extension Received
Jun 28, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 26, 2023
Sou Extension 3 Granted
Jun 26, 2023
Sou Extension 3 Filed
Jun 26, 2023
Sou Teas Extension Received
Apr 17, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 17, 2023
Teas Change Of Correspondence Received
Apr 17, 2023
Teas Change Of Owner Address Received
Feb 25, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 23, 2023
Sou Extension 2 Granted
Feb 23, 2023
Sou Extension 2 Filed
Feb 23, 2023
Sou Teas Extension Received
Sep 10, 2022
Notice Of Approval Of Extension Request E-Mailed
Sep 8, 2022
Sou Extension 1 Granted
Sep 8, 2022
Sou Extension 1 Filed
Sep 8, 2022
Sou Teas Extension Received
Mar 8, 2022
Noa E-Mailed - Sou Required From Applicant
Jan 11, 2022
Official Gazette Publication Confirmation E-Mailed
Jan 11, 2022
Published For Opposition
Dec 22, 2021
Notification Of Notice Of Publication E-Mailed
Dec 7, 2021
Approved For Pub - Principal Register
Dec 6, 2021
Assigned To Examiner
Oct 13, 2021
New Application Office Supplied Data Entered
Sep 2, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
